Levin Capital Strategies’s Colgate-Palmolive CL Stock Holding History

Levin Capital Strategies’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,445	Closed	-$517K	–	252
2022 Q2	$517K	Hold	6,445	–	–	0.06%	126
2022 Q1	$489K	Hold	6,445	–	–	0.05%	162
2021 Q4	$550K	Hold	6,445	–	–	0.05%	145
2021 Q3	$487K	Hold	6,445	–	–	0.05%	171
2021 Q2	$524K	Hold	6,445	–	–	0.05%	156
2021 Q1	$508K	Hold	6,445	–	–	0.05%	142
2020 Q4	$551K	Hold	6,445	–	–	0.06%	136
2020 Q3	$497K	Buy	+6,445	New	+$491K	0.07%	136
2018 Q1	–	Sell	-5,709	Closed	-$431K	–	314
2017 Q4	$431K	Buy	5,709 +2,209	+63%	+$161K	0.01%	207
2017 Q3	$255K	Sell	3,500 -500	-13%	-$36K	﹤0.01%	277
2017 Q2	$297K	Buy	+4,000	New	+$297K	0.01%	244
2016 Q2	–	Sell	-3,500	Closed	-$247K	–	345
2016 Q1	$247K	Hold	3,500	–	–	﹤0.01%	288
2015 Q4	$233K	Sell	3,500 -4,000	-53%	-$266K	﹤0.01%	315
2015 Q3	$476K	Buy	+7,500	New	+$490K	0.01%	257

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Levin Capital Strategies's CL Position: Q3 2022 in Review

Levin Capital Strategies sold out of Colgate-Palmolive (CL) in Q3 2022, closing a stake of 6,445 shares — an estimated $517K sold.

Levin Capital Strategies first reported a position in CL in Q3 2015 and held it in 14 quarters. The position peaked at $551K in Q4 2020. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

Levin Capital Strategies reported no remaining Colgate-Palmolive position as of Q3 2022 after selling out during the quarter.
Levin Capital Strategies sold 6,445 Colgate-Palmolive shares in Q3 2022, an estimated $517K.
Levin Capital Strategies first reported a position in Colgate-Palmolive in Q3 2015 and held it in 14 quarters.
Levin Capital Strategies's Colgate-Palmolive position peaked at $551K in Q4 2020.
1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Levin Capital Strategies's 13F filing for Q3 2022, filed 8 Nov 2022.